Literature DB >> 15121011

Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells.

Weibiao Huang1, Brian Carlsen, George Rudkin, Micah Berry, Kenji Ishida, Dean T Yamaguchi, Timothy A Miller.   

Abstract

Osteopontin (OPN) is an important mediator of bone remodeling. However, the role of OPN in the process of bone formation is not fully understood. In previous studies, we have shown that MC3T3-E1 pre-osteoblastic cells at higher passage number exhibited weakened osteogenic capacity and elevated OPN mRNA expression. In this work, we investigated the role of OPN on proliferation and differentiation of low-passage MC3T3-E1 cells by studying stable cell lines overexpressing either OPN mRNA or its antisense RNA. Overexpression was verified by both Northern and Western blot analyses. Overexpression of OPN markedly inhibited proliferation as determined by daily cell counts, while overexpression of antisense RNA stimulated cellular proliferation. We also examined the effect of OPN level on BMP-2-induced alkaline phosphatase activity. Overexpression of OPN inhibited BMP-2 responsiveness while overexpression of antisense RNA enhanced the effect of BMP-2 on alkaline phosphatase activity. Increased OPN expression also caused decreases in expression of osteocalcin and bone sialoproteins while a reduction of OPN level caused the opposite. Furthermore, endogenous OPN expression in response to BMP-2 exhibited a biphasic pattern, that is, it was initially inhibited and then enhanced by the treatment of BMP-2, indicating that OPN might function as a negative feedback regulator for osteoblastic differentiation. Finally, overexpression of OPN inhibited mineral deposition. In contrast, overexpression of antisense RNA enhanced mineral deposition. These results indicate that OPN is a negative regulator of proliferation and differentiation in MC3T3-E1 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121011     DOI: 10.1016/j.bone.2003.11.027

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  27 in total

1.  Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.

Authors:  Gábor Valcz; Ferenc Sipos; Tibor Krenács; Jeannette Molnár; Arpád V Patai; Katalin Leiszter; Kinga Tóth; Norbert Solymosi; Orsolya Galamb; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2010-03-27       Impact factor: 3.201

2.  Overexpression of PLAP-1 in bone marrow stromal cells inhibits the rat critical-size skull defect repair.

Authors:  Xijiao Yu; Jing Sun; Ying Hu; Yan Gao; Changjie Xiao; Shuang Liu; Shu Li
Journal:  J Mol Histol       Date:  2015-06-02       Impact factor: 2.611

3.  Overexpression of the PLAP-1 gene inhibits the differentiation of BMSCs into osteoblast-like cells.

Authors:  Jing Sun; Ting Zhang; Panpan Zhang; Linlin Lv; Yanzhi Wang; Jing Zhang; Shu Li
Journal:  J Mol Histol       Date:  2014-07-20       Impact factor: 2.611

4.  In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  J Pharm Sci       Date:  2013-12-30       Impact factor: 3.534

5.  Cationic Nanogel-mediated Runx2 and Osterix siRNA Delivery Decreases Mineralization in MC3T3 Cells.

Authors:  Arun R Shrivats; Eric Hsu; Saadyah Averick; Molly Klimak; April C S Watt; Marlene DeMaio; Krzysztof Matyjaszewski; Jeffrey O Hollinger
Journal:  Clin Orthop Relat Res       Date:  2014-12-02       Impact factor: 4.176

6.  High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes.

Authors:  T Filardi; V Carnevale; R Massoud; C Russo; L Nieddu; F Tavaglione; I Turinese; A Lenzi; E Romagnoli; S Morano
Journal:  J Endocrinol Invest       Date:  2018-06-18       Impact factor: 4.256

7.  Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-01-10       Impact factor: 7.328

8.  Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Charles Hoover; Marija Vukomanović; Dragan P Uskoković; Tejal A Desai
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-04-13       Impact factor: 7.328

9.  Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts.

Authors:  Noriaki Ono; Kazuhisa Nakashima; Susan R Rittling; Ernestina Schipani; Tadayoshi Hayata; Kunimichi Soma; David T Denhardt; Henry M Kronenberg; Yoichi Ezura; Masaki Noda
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

10.  Regulatory role of osteopontin in malignant transformation of endometrial cancer.

Authors:  Sabarish Ramachandran; Kun-Young Kwon; So-Jin Shin; Sang-Hoon Kwon; Soon-Do Cha; Hyun-Gyo Lee; Young-Bin Hong; Insoo Bae; Gun-Ho Lee; Chi-Heum Cho
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.